XAF1 and COVID-19: Our data and other clinical data sets have suggested that elevated XAF1 expression is positively correlated with the SARS-CoV, MERS-CoV, and SARS-CoV-2 infection in the lungs (49, 50) as well as the symptoms of the COVID-19 and influenza patients (51).